Eli Lilly, Cipla ink pact for Humalog,Trulicity to treat diabetes
New Delhi: Eli Lilly and Company (India) Pvt. Ltd., is a wholly owned subsidiary of Eli Lilly and Company, a global biopharmaceutical company headquartered in Indianapolis, USA. and Cipla Limited announced a strategic partnership in India to enhance the reach of Lilly's Diabetes products – Humalog [Insulin Lispro I.P. (rDNA Origin) injection] and Trulicity (Dulaglutide).